Biohaven (BHVN) Earnings Date & Reports

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

BHVN is expected to report earnings to fall 12.44% to -189 cents per share on August 04

Q2'25

Est.

$-1.90

Q1'25

Missed

by $0.47

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.04

Q2'24

Missed

by $1.72

The last earnings report on May 12 showed earnings per share of -217 cents, missing the estimate of -170 cents. With 2.46M shares outstanding, the current market capitalization sits at 1.51B.

View a ticker or compare two or three

Compare

BHVN